Does the degree of hormone receptor positivity influence your decision to perform Oncotype testing?
Since HR low-positive, HER2 neg tumors behave aggressively similar to TNBC, does the degree of HR positivity factor into your decision-making?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Hawai'i Cancer Center
Answered on
In my clinical practice, the degree of hormone receptor (HR) positivity and the clinical characteristics play an important role in ordering the Oncotype testing for HER2-negative tumors. But for 10 to 100%, if the patient is a candidate for chemo or the patient is willing to use this test as part of...
Join for free or sign in to see the full answer